Natural History of Patients with Multiple Myeloma Refractory to Elotuzumab and Outcomes of Subsequent Therapy with Anti-CD38 Monoclonal Antibodies Varnado, W., Jagosky, M., Gahvari, Z., Chhabra, S., Gandhi, U. H., Lakshman, A., McGehee, E., Gupta, R., Malek, E., Fiala, M. A., Mansour, J., Paul, B., Barnstead, A., Kodali, S., Amarendra, N., Liedtke, M., Godby, K. N., Kang, Y., Kansgra, A., Scott, E. C., Umyarova, E., Hari, P., Vij, R., Usmani, S. Z., Cornell, R., Kumar, S. K., Callander, N., Costa, L. J. AMER SOC HEMATOLOGY. 2018

View details for DOI 10.1182/blood-2018-99-112246

View details for Web of Science ID 000454842801095